An observational study in Birth Rate, Embryo Implantation and Reproductive Techniques, sponsored by G. d'Annunzio University. Completed at 1 site in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-08-08.
Sponsored by G. d'Annunzio University · Observational
Both hereditary and acquired thrombophilia have been associated with recurrent miscarriage and pregnancy complications. Thrombophilia could favor the development of thrombosis of the maternal vasculature and obstacle placentation. Some studies have suggested a role of thrombophilia in the failure of assisted reproductive techniques although this association has been recently questioned. The scope of this study is to evaluate the effect of thrombophilia on the implantation rate and live birth rate in women undergoing ART.
Design: prospective, observational study Primary end-point: live birth rate. Secondary end-points: implantation rate, venous thromboembolic events during ART up to 6 weeks post-partum
75 studies on the registry are indexed under Thrombophilia; 16 are open to participants now.
This study's enrollment of 687 is above the median of 106 across 50 observational studies indexed under Thrombophilia.
Browse Thrombophilia studies →G. d'Annunzio University is the lead sponsor of 62 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All women 18 years or older undergoing ART
Exclusion Criteria:
Live birth rate
Time frame: Participants will be followed for the duration of the pregnancy, an expected average of 9 months
implantation rate
Time frame: Participants will be followed from the implantation to the ultrasonography to document the gestational sac, an expected average of 7 weeks
This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
G. d'Annunzio University